Aderans has updated the text on the front page of their website:
"Aderans Research Institute (ARI) is a leading commercial force in the field of hair regeneration, pioneering innovative cell-based solutions to the problems of pattern hair loss that affect millions of people around the world. Historically, hair transplantation has been limited by the number of available hairs on the head in question, but cellular regeneration may make it possible to multiply hairs, providing a potentially unlimited supply of hair growth for up to 80 million Americans suffering from pattern hair loss. With rejuvenated hair follicles producing healthy hair, people can get back to the business of leading confident, productive lives.
We invite anyone facing the challenge of hair loss to consider participating in our clinical study, and we invite members of the investment community to explore our cellular regeneration process in greater depth. "
The last paragraph concerns me a bit. They are appealing to investors. Regardless, Aderans has awaken from a four-year coma. They are in the news again and they are making press releases. I will remain cautious since they are still in phase 2 trials. That being said, this is very exciting. A year or two from now, it is possible that we will hear about Aderans phase 3 trials…which would mean they are only one phase away from market. Awesome.